{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T18:08:25Z","timestamp":1785262105266,"version":"3.55.0"},"reference-count":45,"publisher":"Aging and Disease","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging and disease"],"published-print":{"date-parts":[[2017]]},"DOI":"10.14336\/ad.2017.0130","type":"journal-article","created":{"date-parts":[[2018,4,2]],"date-time":"2018-04-02T18:48:41Z","timestamp":1522694921000},"page":"583","source":"Crossref","is-referenced-by-count":59,"title":["Recognizing Degenerative Aging as a Treatable Medical Condition: Methodology and Policy"],"prefix":"10.14336","volume":"8","author":[{"given":"Ilia","family":"Stambler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5462","reference":[{"key":"key-10.14336\/AD.2017.0130-1","doi-asserted-by":"crossref","unstructured":"Jin K, Simpkins JW, Ji X, Leis M, Stambler I (2015). The critical need to promote research of aging and aging-related diseases to improve health and longevity of the elderly population. Aging Dis, 6(1):1-5.","DOI":"10.14336\/AD.2014.1210"},{"key":"key-10.14336\/AD.2017.0130-2","doi-asserted-by":"crossref","unstructured":"Rae MJ, Butler RN, Campisi J, de Grey ADNJ, Finch CE, Gough M, et al. (2010). The demographic and biomedical case for late-life interventions in aging. Sci Transl Med, 2(40): 40cm21.","DOI":"10.1126\/scitranslmed.3000822"},{"key":"key-10.14336\/AD.2017.0130-3","doi-asserted-by":"crossref","unstructured":"Goldman DP, Cutler D, Rowe JW, Michaud PC, Sullivan J, Peneva D, Olshansky SJ (2013). Substantial health and economic returns from delayed aging may warrant a new focus for medical research. Health Aff, 32(10): 1698-1705.","DOI":"10.1377\/hlthaff.2013.0052"},{"key":"key-10.14336\/AD.2017.0130-4","doi-asserted-by":"crossref","unstructured":"Fontana L, Kennedy BK, Longo VD, Seals D, Melov S (2014). Medical research: treat ageing. Nature, 511(7510): 405-407.","DOI":"10.1038\/511405a"},{"key":"key-10.14336\/AD.2017.0130-5","doi-asserted-by":"crossref","unstructured":"Zhavoronkov A, Bhullar B. Classifying aging as a disease in the context of ICD-11 (2015). Front Genet, 6:326.","DOI":"10.3389\/fgene.2015.00326"},{"key":"key-10.14336\/AD.2017.0130-6","doi-asserted-by":"crossref","unstructured":"Bulterijs S, Hull RS, Bj\u00f6rk VCE, Roy AG (2015). It is time to classify biological aging as a disease. Front Genet, 6: 205.","DOI":"10.3389\/fgene.2015.00205"},{"key":"key-10.14336\/AD.2017.0130-7","doi-asserted-by":"crossref","unstructured":"Stambler I (2015). Has aging ever been considered healthy? Front Genet, 6: 202.","DOI":"10.3389\/fgene.2015.00202"},{"key":"key-10.14336\/AD.2017.0130-8","unstructured":"Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. (2013). Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 380(9859): 2095-2128."},{"key":"key-10.14336\/AD.2017.0130-9","unstructured":"Murray CJL, Lopez AD. Estimating causes of death: new methods and global and regional application for 1990. In: Murray CJLLopez AD, editors. Global Burden of Disease and Injury Series. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Boston: Harvard School of Public Health, on behalf of the World Health Organization and the World Bank; 1996, pp. 117-200."},{"key":"key-10.14336\/AD.2017.0130-10","doi-asserted-by":"crossref","unstructured":"Ahmad A, Komai S (2015). Geriatrics and gerontology: neglected areas of research in most developing countries. J Am Geriatr Soc, 63(6): 1283-1284.","DOI":"10.1111\/jgs.13521"},{"key":"key-10.14336\/AD.2017.0130-11","unstructured":"EMA geriatric medicines strategy. EMA\/CHMP\/137793\/2011. London: European Medicines Agency; 2011."},{"key":"key-10.14336\/AD.2017.0130-12","unstructured":"EMA geriatric medicines strategy. Report analysis on product information. EMA\/352652\/2013. London: European Medicines Agency; 2013."},{"key":"key-10.14336\/AD.2017.0130-13","unstructured":"Concept paper on the need for a reflection paper on quality aspects of medicines for older people. EMA\/165974\/2013. London: European Medicines Agency; 2013."},{"key":"key-10.14336\/AD.2017.0130-14","unstructured":"Proposal for the development of a points to consider for baseline characterisation of frailty status. EMA\/335158\/2013. London: European Medicines Agency; 2013."},{"key":"key-10.14336\/AD.2017.0130-15","doi-asserted-by":"crossref","unstructured":"Cesari M, Fielding R, B\u00e9nichou O, Bernabei R, Bhasin S, Guralnik JM, et al. (2015). Pharmacological interventions in frailty and sarcopenia: Report by the International Conference on Frailty and Sarcopenia Task Force. J Frailty Aging, 4(3): 114-120.","DOI":"10.14283\/jfa.2015.64"},{"key":"key-10.14336\/AD.2017.0130-16","doi-asserted-by":"crossref","unstructured":"Hall SS (2015). A trial for the ages. Science, 349(6254): 1275-1278.","DOI":"10.1126\/science.349.6254.1274"},{"key":"key-10.14336\/AD.2017.0130-17","unstructured":"Blokh D, Stambler I (2016). The application of information theory for the research of aging and aging-related diseases. Prog Neurobiol, S0301-0082(15): 30059-9."},{"key":"key-10.14336\/AD.2017.0130-18","doi-asserted-by":"crossref","unstructured":"Moskalev A, Chernyagina E, Tsvetkov V, Fedintsev A, Shaposhnikov M, Krut\u2019ko V, Zhavoronkov A, Kennedy BK (2016). Developing criteria for evaluation of geroprotectors as a key stage toward translation to the clinic. Aging Cell, 15(3): 407-415.","DOI":"10.1111\/acel.12463"},{"key":"key-10.14336\/AD.2017.0130-19","unstructured":"Fried LP, Walston J. Frailty and failure to thrive. In: Hazzard WR, Blass JP, Ettinger WH, Halter JB, Ouslander MD, editors. Principles of Geriatric Medicine and Gerontology. 4th ed. New York: McGraw Hill; 1999, pp 1387-1402."},{"key":"key-10.14336\/AD.2017.0130-20","doi-asserted-by":"crossref","unstructured":"Ensrud KE, Ewing SK, Cawthon PM, Fink HA, Taylor BC, Cauley JA, et al. (2009). Osteoporotic Fractures in Men Research Group. A comparison of frailty indexes for the prediction of falls, disability, fractures, and mortality in older men. J Am Geriatr Soc, 57(3):492-498.","DOI":"10.1111\/j.1532-5415.2009.02137.x"},{"key":"key-10.14336\/AD.2017.0130-21","doi-asserted-by":"crossref","unstructured":"Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. (2001). Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci, 56(3):M146-M156.","DOI":"10.1093\/gerona\/56.3.M146"},{"key":"key-10.14336\/AD.2017.0130-22","doi-asserted-by":"crossref","unstructured":"Mitnitski AB, Mogilner AJ, Rockwood K (2001). Accumulation of deficits as a proxy measure of aging. ScientificWorldJournal, 1:323-336.","DOI":"10.1100\/tsw.2001.58"},{"key":"key-10.14336\/AD.2017.0130-23","doi-asserted-by":"crossref","unstructured":"Mayevsky A, Barbiro-Michaely E (2013). Shedding light on mitochondrial function by real time monitoring of NADH fluorescence: II: human studies. J Clin Monit Comput, 27(2):125-145.","DOI":"10.1007\/s10877-012-9413-6"},{"key":"key-10.14336\/AD.2017.0130-24","doi-asserted-by":"crossref","unstructured":"Zarchin N, Meilin S, Rifkind J, Mayevsky A (2002). Effect of aging on brain energy-metabolism. Comp Biochem Physiol A Mol Integr Physiol, 132(1):117-120.","DOI":"10.1016\/S1095-6433(01)00537-2"},{"key":"key-10.14336\/AD.2017.0130-25","doi-asserted-by":"crossref","unstructured":"Fuellen G, Schofield P, Flatt T, Schulz RJ, Boege F, Kraft K, et al. (2016). Living long and well: Prospects for a personalized approach to the medicine of ageing. Gerontology, 62(4):409-416.","DOI":"10.1159\/000442746"},{"key":"key-10.14336\/AD.2017.0130-26","doi-asserted-by":"crossref","unstructured":"Hartshorne JK, Germine LT (2015). When does cognitive functioning peak? The asynchronous rise and fall of different cognitive abilities across the life span. Psychol Sci, 26(4):433-443.","DOI":"10.1177\/0956797614567339"},{"key":"key-10.14336\/AD.2017.0130-27","unstructured":"De Grey ADNJ, Rae M. Ending Aging: The Rejuvenation Breakthroughs That Could Reverse Human Aging in Our Lifetime. New York: St. Martin\u2019s Press; 2007."},{"key":"key-10.14336\/AD.2017.0130-28","doi-asserted-by":"crossref","unstructured":"Kennedy BK, Berger SL, Brunet A, Campisi J, Cuervo AM, Epel ES (2014). Geroscience: linking aging to chronic disease. Cell, 59:709-713.","DOI":"10.1016\/j.cell.2014.10.039"},{"key":"key-10.14336\/AD.2017.0130-29","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Ot\u00edn C, Blasco MA, Partridge L, Serrano M, Kroemer G (2013). The hallmarks of aging. Cell, 153:1194-1217.","DOI":"10.1016\/j.cell.2013.05.039"},{"key":"key-10.14336\/AD.2017.0130-30","doi-asserted-by":"crossref","unstructured":"Moskalev A, Chernyagina E, Kudryavtseva A, Shaposhnikov M (2017). Geroprotectors: a unified concept and screening approaches. Aging Dis, 4(8).","DOI":"10.14336\/AD.2016.1022"},{"key":"key-10.14336\/AD.2017.0130-31","doi-asserted-by":"crossref","unstructured":"Blokh D, Stambler I (2017). The use of information theory for the evaluation of biomarkers of aging and physiological age. Mech Ageing Dev, S0047-6374(16)30156-7.","DOI":"10.1016\/j.mad.2017.01.003"},{"key":"key-10.14336\/AD.2017.0130-32","doi-asserted-by":"crossref","unstructured":"Reiman EM, Langbaum JB, Fleisher AS, Caselli RJ, Chen K, Ayutyanont N, et al. (2011). Alzheimer\u2019s Prevention Initiative: A plan to accelerate the evaluation of presymptomatic treatments. J Alzheimers Dis, 26(Suppl 3): 321-329.","DOI":"10.3233\/JAD-2011-0059"},{"key":"key-10.14336\/AD.2017.0130-33","doi-asserted-by":"crossref","unstructured":"Toyn J (2015). What lessons can be learned from failed Alzheimer\u2019s disease trials? Expert Rev Clin Pharmacol, 8(3): 267-269.","DOI":"10.1586\/17512433.2015.1034690"},{"key":"key-10.14336\/AD.2017.0130-34","doi-asserted-by":"crossref","unstructured":"Morrison DH, Rahardja D, King E, Peng Y, Sarode VR (2012). Tumour biomarker expression relative to age and molecular subtypes of invasive breast cancer. Br J Cancer, 107: 382-387.","DOI":"10.1038\/bjc.2012.219"},{"key":"key-10.14336\/AD.2017.0130-35","doi-asserted-by":"crossref","unstructured":"Cohen AA (2016). Complex systems dynamics in aging: new evidence, continuing questions. Biogerontology, 17: 205-220.","DOI":"10.1007\/s10522-015-9584-x"},{"key":"key-10.14336\/AD.2017.0130-36","doi-asserted-by":"crossref","unstructured":"Le Couteur DG, Simpson SJ (2011). Adaptive senectitude: the prolongevity effects of aging. J Gerontol A Biol Sci Med Sci, 66: 179-182.","DOI":"10.1093\/gerona\/glq171"},{"key":"key-10.14336\/AD.2017.0130-37","doi-asserted-by":"crossref","unstructured":"Blokh D, Stambler I (2015). Applying information theory analysis for the solution of biomedical data processing problems. Am J Bioinform, 3(1): 17-29.","DOI":"10.3844\/ajbsp.2014.17.29"},{"key":"key-10.14336\/AD.2017.0130-38","doi-asserted-by":"crossref","unstructured":"Khokhlov AN (2010). From Carrel to Hayflick and back or what we got from the 100 years of cytogerontological studies. Biophysics, 55(5): 859-864.","DOI":"10.1134\/S0006350910050313"},{"key":"key-10.14336\/AD.2017.0130-39","doi-asserted-by":"crossref","unstructured":"Safar P (2000). On the future of reanimatology. Acad Emerg Med, 7(1): 75-89.","DOI":"10.1111\/j.1553-2712.2000.tb01898.x"},{"key":"key-10.14336\/AD.2017.0130-40","doi-asserted-by":"crossref","unstructured":"Rogatsky GG, Shifrin EG, Mayevsky A (2003). Optimal dosing as a necessary condition for the efficacy of hyperbaric oxygen therapy in acute ischemic stroke: a critical review. Neurol Res, 25(1): 95-98.","DOI":"10.1179\/016164103101201003"},{"key":"key-10.14336\/AD.2017.0130-41","doi-asserted-by":"crossref","unstructured":"Gerasimenko YP, Lu DC, Modaber M, Zdunowski S, Gad P, Sayenko DG, et al. (2015). Noninvasive reactivation of motor descending control after paralysis. J. Neurotrauma, 32(24): 1968-1980.","DOI":"10.1089\/neu.2015.4008"},{"key":"key-10.14336\/AD.2017.0130-42","doi-asserted-by":"crossref","unstructured":"Blokh D, Stambler I (2015). Information theoretical analysis of aging as a risk factor for heart disease. Aging Dis, 6(3): 196-207.","DOI":"10.14336\/AD.2014.0623"},{"key":"key-10.14336\/AD.2017.0130-43","unstructured":"Blokh D, Stambler I (2014). Estimation of heterogeneity in diagnostic parameters of age-related diseases. Aging Dis, 5(4): 218-225."},{"key":"key-10.14336\/AD.2017.0130-44","unstructured":"Farber GK (2016). Can data repositories help find effective treatments for complex diseases? Prog Neurobiol, S0301-0082(15)30025-3."},{"key":"key-10.14336\/AD.2017.0130-45","unstructured":"Stambler I. Life extension: opportunities, challenges, and implications for public health policy. In: Vaiserman A, editor. Anti-aging Drugs: From Basic Research to Clinical Practice. London: Royal Society of Chemistry; 2017, pp. 537-564."}],"container-title":["Aging and disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.aginganddisease.org\/fileup\/2152-5250\/PDF\/2152-5250-2017-5-583.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T22:59:46Z","timestamp":1627772386000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.aginganddisease.org\/EN\/10.14336\/AD.2017.0130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.14336\/ad.2017.0130","relation":{},"ISSN":["2152-5250"],"issn-type":[{"value":"2152-5250","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}